Tedros’ 10-Point Proposal for Reforming Global Emergency Response Gets Mixed Review 30/01/2023 Elaine Ruth Fletcher A new 10-point proposal by the World Health Organization’s Director General Dr Tedros Adhanom Ghebreyesus for improving preparedness and response to health emergencies received mixed reviews from WHO member states in Monday’s opening session of this week’s Executive Board (EB) meeting, the agency’s 34-member governing body. It was the first substantive issue to be tackled […] Continue reading -> UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
UK Scientists Launch Genomic Surveillance System for Respiratory Viruses 12/01/2023 Stefan Anderson British scientists have launched a new initiative to expand the sequencing of common seasonal respiratory viruses with the aim of developing an early warning system for new viral threats and help prevent future pandemics. At the height of the COVID-19 pandemic, labs around the world were sequencing tens of thousands of Sars-CoV-2 genomes a day. […] Continue reading -> Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Divided World Trade Organization Presses to Delay Decision on IP Waiver for COVID Treatments 16/12/2022 John Heilprin The World Trade Organization (WTO) TRIPS Council agreed to recommend to the General Council, WTO’s highest-level decision-making body, that it extend Saturday’s deadline for deciding on whether to extend an intellectual property rights waiver for COVID-19 vaccines to diagnostics and therapeutics. The panel’s recommendation on Friday at a formal meeting chaired by Ambassador Lansana Gberie […] Continue reading -> Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Montreal’s Convention on Biodiversity Conference Could Determine our Response to Future Pathogens 16/12/2022 Pamela Fralick & Thomas B. Cueni This month, world leaders gathered in Montreal for a major UN conference on biodiversity, aiming to reach an agreement on how to stop species loss. The Fifteenth Conference of the Parties to the Convention on Biological Diversity (CBD) – COP15 for short– has drawn tens of thousands of people. Delayed several times, it is the first […] Continue reading -> As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
As WTO Considers Patent Waiver on COVID Treatments, Some Say it is Too Late 24/11/2022 Kerry Cullinan Little agreement emerged from an informal World Trade Organization (WTO) meeting on Tuesday about whether an intellectual property (IP) waiver should be extended to COVID-19 therapeutics and diagnostics. But low and middle-income countries (LMIC) that qualify for free COVID-19 anti-virals Paxlovid (nirmatrelvir) and Molnupiravir have shown so little interest in accepting donations that some question […] Continue reading -> Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic Treaty ‘Zero-Draft’ Makes a Strong Case for Regional Production 17/11/2022 Kerry Cullinan Regional production of vaccines and other pandemic-related products – and sharing the technical know-how to enable this – features strongly in the much-anticipated first draft of the global pandemic treaty proposed by the World Health Organization (WHO) to guide future pandemics. WHO member states will be briefed on the conceptual “zero-sum” draft on Friday in […] Continue reading -> How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
How Do You Spell Deadlock? T-R-I-P-S 11/11/2022 Jamil Chade Deadlock may once again be the name of the game at the World Trade Organization’s (WTO’s) Council for Trade-Related Aspects of Intellectual Property Rights—TRIPS, for short. A communication from Switzerland and Mexico questioning the need to extend the waiver on intellectual property rights on COVID-19 vaccines to therapeutics and diagnostics is laying bare the divergences […] Continue reading -> Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Private-Public Drug Deal Enables Generic Production of Expensive Cancer Medicine 20/10/2022 Kerry Cullinan A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading -> A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A ‘Simple Career’: The Untold Story of Bernard Pécoul and a Paradigm Shift in Global Health 10/10/2022 Stefan Anderson Under the leadership of Dr Bernard Pécoul, the Drugs for Neglected Diseases Initiative became one of the flagship programmes for research and development into diseases affecting the world’s most forgotten people. He has contributed to the betterment of the lives of millions, yet few outside global health circles know his name. This is his story. […] Continue reading -> Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Advocates Mount New Initiative for WTO to Recognize ‘Public Goods’ in Trade Agreements – from Medicines to Forests 30/09/2022 John Heilprin At a World Trade Organization Public Forum this week, public health advocates argued for the creation of a new WTO framework to stimulate voluntary offers by countries to supply more ‘public goods’ to trading partners and the world, including investments, assets and know-how critical to protecting the world against future pandemics and other health or […] Continue reading -> Posts navigation Older postsNewer posts